Green Light for Boston Biolab?

A controversial Boston University laboratory could open by the end of the month, but at a lower safety rating than originally planned.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A researcher working in a biosafety level 3-enhanced laboratory setting WIKIMEDIA COMMONS, CDC'S PUBLIC HEALTH IMAGE LIBRARY

The Massachusetts Executive Office of Energy and Environmental Affairs last week (December 2) granted preliminary approval for Boston University to open its long awaited and highly controversial biomedical research laboratory, but only for work on less hazardous substances than originally proposed, The Boston Globe reported. In addition, the environmental agency is requiring another round of public comment, starting today (December 7) and lasting 2 two weeks. After that, the agency says it will consider issuing the final approval for the lab to begin biosafety level-2 research, which involves “agents that pose moderate hazards to personnel and the environment,” according to the federal government’s definition.

“BU researchers will focus on Tuberculosis and experiments that have been approved for the [biosafety level-2] laboratories,” the University said in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo